Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Starry-Sky Projection and Maternal Voice for Sleep After Pediatric Cardiac Surgery

28 octobre 2026 mis à jour par: Biyu Shen, Shanghai Jiao Tong University School of Medicine

Effects of Starry-Sky Projection and Maternal Voice on Postoperative Sleep in Children Undergoing Cardiac Surgery: A 2 × 2 Factorial Randomized Controlled Trial

The goal of this clinical trial is to determine whether a starry-sky projection affects sleep during the early period after cardiac surgery in young children. The main question it aims to answer is:

• Does a starry-sky projection improve how well children sleep during the first three nights after surgery compared with routine nighttime lighting? The study will also explore whether sleep outcomes differ between children who listen to their mother's recorded voice and those who listen to an unfamiliar woman's recorded voice, and whether the effect of the starry-sky projection differs depending on the type of voice.

Children aged 6 months to 6 years will be randomly assigned to one of four combinations of visual and sound conditions. They will:

  • Receive either a starry-sky projection or routine nighttime lighting
  • Listen to either their mother's recorded voice or an unfamiliar woman's recorded voice
  • Have their sleep monitored during the first three nights after surgery using a contactless device placed under the pillow that does not require sensors attached to the child.

Aperçu de l'étude

Type d'étude

Interventionnel

Inscription (Estimé)

172

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

  • Nom: Biyu Shen, PhD
  • Numéro de téléphone: +86 13862937317
  • E-mail: shenbiyu@126.com

Lieux d'étude

    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, Chine, 200127
        • Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine
        • Contact:
          • Biyu Shen, PhD
          • Numéro de téléphone: +86 13862937317
          • E-mail: shenbiyu@126.com

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

6 mois à 6 ans (Enfant)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • A confirmed diagnosis of congenital heart disease.
  • Age between 6 months and 6 years.
  • Scheduled to undergo their first elective open-heart surgery.
  • An anticipated postoperative stay in the cardiac intensive care unit (CICU) of at least 48 hours.
  • Written informed consent provided by a parent or legal guardian.

Exclusion Criteria:

  • Epilepsy or another severe neurological disorder.
  • A severe psychiatric disorder.
  • Hearing impairment that interferes with the perception of auditory stimuli.
  • Visual impairment that interferes with the perception of visual stimuli.
  • Malformations of other organs or pre-existing severe comorbidities.
  • A history of chronic pain.
  • A previously diagnosed sleep disorder.
  • Endotracheal tube could not be successfully removed before 7 p.m. on the day of surgery.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Soins de soutien
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation factorielle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Starry-Sky Projection + Maternal Voice

A starry-sky projector will display gently moving, diffuse star-like points on the ceiling, avoiding direct light exposure to the child's eyes. Settings will remain constant, without rapid movement, frequent colour changes, or visible flicker. Built-in audio will be disabled. Sessions will last 30 minutes before anticipated sleep onset on postoperative nights 0-2.

A personalised recording from the child's mother containing the child's name, reassuring and sleep-related phrases, and a familiar lullaby or gentle melody will be played for 30 minutes before anticipated sleep onset. The recording will be played using a speaker positioned approximately 20 cm from the child's ear, with sound intensity maintained at 45-50 dB.

Expérimental: Starry-Sky Projection + Unfamiliar Female Voice

A starry-sky projector will display gently moving, diffuse star-like points on the ceiling, avoiding direct light exposure to the child's eyes. Settings will remain constant, without rapid movement, frequent colour changes, or visible flicker. Built-in audio will be disabled. Sessions will last 30 minutes before anticipated sleep onset on postoperative nights 0-2.

A standardized recording by an unfamiliar adult woman who is not involved in the child's clinical care will be played for 30 minutes before anticipated sleep onset. The recording will contain generic reassuring and sleep-related phrases and a gentle lullaby or nursery rhyme. Playback duration, speaker placement, and sound intensity will be identical to the maternal voice condition.

Comparateur actif: Conventional Lighting + Maternal Voice

A personalised recording from the child's mother containing the child's name, reassuring and sleep-related phrases, and a familiar lullaby or gentle melody will be played for 30 minutes before anticipated sleep onset. The recording will be played using a speaker positioned approximately 20 cm from the child's ear, with sound intensity maintained at 45-50 dB.

Participants will remain under routine nocturnal lighting in the CICU or general ward without additional projection.

Comparateur actif: Conventional Lighting + Unfamiliar Female Voice

A standardized recording by an unfamiliar adult woman who is not involved in the child's clinical care will be played for 30 minutes before anticipated sleep onset. The recording will contain generic reassuring and sleep-related phrases and a gentle lullaby or nursery rhyme. Playback duration, speaker placement, and sound intensity will be identical to the maternal voice condition.

Participants will remain under routine nocturnal lighting in the CICU or general ward without additional projection.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Sleep Efficiency
Délai: Postoperative nights 0, 1, and 2

Sleep efficiency is defined as the percentage of total sleep time (TST) relative to time in bed (TIB) during the sleep-related nocturnal interval. TIB refers to the interval from the start of an attempt to sleep until the end of the nocturnal sleep opportunity and includes sleep onset latency and intervening wakefulness. Sleep efficiency will be assessed using a contactless ballistocardiography (BCG)-based sleep monitoring mat during postoperative nights 0-2. The mean sleep efficiency across the three postoperative nights will be used as the primary outcome measure. Higher values indicate better sleep efficiency.

Postoperative nights 0, 1, and 2

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Total Sleep Time
Délai: Postoperative nights 0, 1, and 2

Total sleep time during the nocturnal monitoring period, measured using a contactless sleep monitoring mat.

Postoperative nights 0, 1, and 2
Sleep-Onset Latency
Délai: Postoperative nights 0, 1, and 2

Time from the beginning of the nocturnal sleep monitoring period to sleep onset, measured using a contactless sleep monitoring mat.

Postoperative nights 0, 1, and 2
Wake After Sleep Onset
Délai: Postoperative nights 0, 1, and 2

Total duration of wakefulness occurring after sleep onset during the nocturnal monitoring period, measured using a contactless sleep monitoring mat.

Postoperative nights 0, 1, and 2
Sleep Fragmentation Index
Délai: Postoperative nights 0, 1, and 2

Sleep fragmentation index derived from the contactless sleep monitoring mat, reflecting the degree of sleep disruption during the nocturnal monitoring period.

Postoperative nights 0, 1, and 2
Sleep-Stage Distribution
Délai: Postoperative nights 0, 1, and 2

Estimated distribution of sleep stages during the nocturnal monitoring period, expressed as the proportion of total sleep time and measured using a contactless sleep monitoring mat.

Postoperative nights 0, 1, and 2
Incidence of Postoperative Delirium
Délai: Postoperative night 0 through postoperative day 2

Postoperative delirium will be assessed using the Cornell Assessment of Pediatric Delirium (CAPD). A total CAPD score ≥9 will indicate a positive delirium screen. Assessments will be performed every 12 hours.

Postoperative night 0 through postoperative day 2
Richmond Agitation-Sedation Scale Score
Délai: Postoperative night 0 through postoperative day 2

Sedation and agitation will be assessed using the Richmond Agitation-Sedation Scale (RASS). Scores range from -5 to +4, with lower scores indicating deeper sedation and higher scores indicating greater agitation. Assessments will be performed every 4 hours.

Postoperative night 0 through postoperative day 2
Pain Score
Délai: Postoperative night 0 through postoperative day 2

Postoperative pain will be assessed using the Face, Legs, Activity, Cry, Consolability (FLACC) scale. Scores range from 0 to 10, with higher scores indicating greater pain severity. Assessments will be performed every 4 hours.

Postoperative night 0 through postoperative day 2
Postoperative Sedative Exposure
Délai: Postoperative day 0 through postoperative day 2

Administration of dexmedetomidine and other sedative medications will be recorded to characterize postoperative sedative exposure.

Postoperative day 0 through postoperative day 2
Postoperative Analgesic Exposure
Délai: Postoperative day 0 through postoperative day 2

Administration of sufentanil and other analgesic medications will be recorded to characterize postoperative analgesic exposure.

Postoperative day 0 through postoperative day 2
Postoperative Vasoactive Medication Exposure
Délai: Postoperative day 0 through postoperative day 2

Administration of dopamine and other vasoactive medications will be recorded to characterize postoperative vasoactive medication exposure.

Postoperative day 0 through postoperative day 2
Heart Rate Variability
Délai: Postoperative nights 0, 1, and 2

Heart rate variability will be continuously measured using the 5S Sleep Tracking Mat as an objective indicator of autonomic regulation.

Postoperative nights 0, 1, and 2
CICU Length of Stay
Délai: Measured in days admitted to the CICU, an average of 2 days

Cardiac intensive care unit (CICU) length of stay will be calculated from postoperative CICU admission to CICU discharge.

Measured in days admitted to the CICU, an average of 2 days
Total Hospital Length of Stay
Délai: Measured in days admitted to the hospital, an average of 10 days.

Total hospital length of stay will be calculated as the number of days from hospital admission to hospital discharge.

Measured in days admitted to the hospital, an average of 10 days.
Parental satisfaction
Délai: On the day of discharge, an average of 10 days

Parental satisfaction with the child's overall hospital care will be assessed using a 100-mm visual analogue scale (VAS), ranging from 0 mm ("very dissatisfied") to 100 mm ("very satisfied"). Higher scores indicate greater satisfaction.

On the day of discharge, an average of 10 days

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

1 novembre 2026

Achèvement primaire (Estimé)

31 mars 2027

Achèvement de l'étude (Estimé)

31 mars 2027

Dates d'inscription aux études

Première soumission

22 septembre 2026

Première soumission répondant aux critères de contrôle qualité

26 septembre 2026

Première publication (Réel)

2 octobre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

30 octobre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

28 octobre 2026

Dernière vérification

1 octobre 2026

Plus d'information

Termes liés à cette étude

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner